Sign in →

Test Code LAB2241 Inhibin B, Serum

Additional Codes

INHB

Useful For

Aiding in the diagnosis of granulosa cell tumors and mucinous epithelial ovarian tumors

 

Monitoring of patients with granulosa cell tumors and epithelial mucinous-type tumors of the ovary known to overexpress inhibin B

 

As an adjunct to follicle-stimulating hormone testing during infertility evaluation

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Specimen Type

Serum


Ordering Guidance


For the initial evaluation of patients suspected of having a granulosa cell tumor of the ovary, order INHAB / Inhibin A and B, Tumor Marker, Serum. If the results of the profile show that either inhibin A or B are elevated, consider monitoring the patient with the individual tests, INHA / Inhibin A, Tumor Marker, Serum or INHB / Inhibin B, Serum.



Specimen Required


Supplies: Sarstedt Aliquot Tube 5 mL (T914)

Collection Container/Tube:

Preferred: Serum gel

Acceptable: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 0.5 mL

Collection Instructions: Centrifuge and aliquot serum into a plastic vial.


Specimen Minimum Volume

0.4 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Refrigerated (preferred) 14 days
  Frozen  90 days
  Ambient  7 days
Medical University of South Carolina Note:

    On-campus collections: Tube to 99 or deliver to University Extension Hospital Room EH318 
 
Off-campus collections: 
Centrifuge and aliquot within 2 hours.
Specimen to be stored/transported Refrigerated

Reference Values

Males

<15 days: 68-373 pg/mL

15-180 days: 42-516 pg/mL

6 months-7 years: 24-300 pg/mL

8-30 years: 47-383 pg/mL

31-72 years: <358 pg/mL

>72 years: Not established

 

Females

≤12 years: <183 pg/mL

13-41 years Regular Cycle (Follicular Phase): <224 pg/mL

42-51 years Regular Cycle (Follicular Phase): <108 pg/mL

13-51 years Regular Cycle (Luteal Phase): <80 pg/mL

>51 years (Postmenopausal): <12 pg/mL

Day(s) Performed

Monday, Wednesday, Friday

CPT Code Information

83520

LOINC Code Information

Test ID Test Order Name Order LOINC Value
INHB Inhibin B, S 56940-0

 

Result ID Test Result Name Result LOINC Value
88722 Inhibin B, S 56940-0

Interpretation

Inhibin B levels are elevated in approximately 89% to 100% of patients with granulosa cell tumors and in approximately 55% to 60% of patients with epithelial ovarian tumors. A normal inhibin B level does not rule out a mucinous or granulosa ovarian cell tumor. Testing for inhibin A in these cases might be informative. Consider ordering INHAB / Inhibin A and B, Tumor Marker, Serum.

 

For monitoring of patients with known ovarian cancer, inhibin B levels decrease to very low or undetectable levels shortly after surgery. Elevations of inhibin B after treatment are suggestive of residual, recurrent, or progressive disease. In patients with recurrent disease, inhibin B elevation seems to be present earlier than clinical symptoms. Patients in remission show normal levels of inhibin B.

 

For infertility evaluation, an inhibin B level in the postmenopausal range is suggestive of a diminished or depleted ovarian reserve.

Method Description

The ultra-sensitive inhibin B enzyme-linked immunosorbent assay is a quantitative three-step sandwich type immunoassay. Sample is incubated in wells that have been coated with inhibin B antibody. After incubation and washing, the wells are incubated with biotinylated inhibin B antibody. After a second incubation and washing step, the wells are incubated with streptavidin horseradish peroxidase conjugate. After the third incubation and washing step, the wells are incubated with substrate solution. After incubation, an acidic stopping solution is added. Antibody-analyte complex is detected by dual wavelength absorbance measurement at 450nm as the primary test filter and 620 nm as the reference filter. The absorbance measured is directly proportional to the concentration of inhibin B in the samples and calibrators.(Unpublished Mayo method)

Report Available

2 to 4 days

Specimen Retention Time

3 months

Reject Due To

Gross hemolysis Reject
Gross lipemia OK
Gross icterus OK

Method Name

Enzyme-Linked Immunosorbent Assay (ELISA)

Forms

If not ordering electronically, complete, print, and send an Oncology Test Request (T729) with the specimen.

Secondary ID

88722